Long-term neuroprotective effects of natalizumab and fingolimod in multiple sclerosis: Evidence from real-world clinical data
-
Published:2024-07
Issue:
Volume:87
Page:105670
-
ISSN:2211-0348
-
Container-title:Multiple Sclerosis and Related Disorders
-
language:en
-
Short-container-title:Multiple Sclerosis and Related Disorders
Author:
Noteboom S.ORCID,
Strijbis E.M.M.,
Coerver E.M.E.,
Colato E.,
van Kempen Z.L.E.,
Jasperse B.,
Vrenken H.,
Killestein J.,
Schoonheim M.M.,
Steenwijk M.D.